Genetic Barcoding of Biomaterial Capsules for Single-Site Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for high-throughput screening of biomaterials for cell encapsulation are costly and inefficient, requiring large numbers of animals for in vivo testing due to the need for multiple implantation sites, which limits the scalability and increases costs significantly.
Innovation Solution
A method involving genetic barcoding of biomaterials using barcode cells, where each biomaterial is tagged with a unique SNP profile, allowing for identification through SNP sequencing after implantation, enabling simultaneous testing of multiple materials at a single site and reducing the need for multiple animal implants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If multiple implantation sites are used to test different biomaterials, then the number of materials that can be tested increases, but the number of animals required increases proportionally
Solution Approach 1:
The patent combines multiple biomaterial tests into a single implantation site by encapsulating different barcode-tagged biomaterials in separate capsules implanted in the same animal. This merging approach allows testing of multiple materials (e.g., 800 beads per site) without proportionally increasing animal numbers, directly resolving the contradiction between screening throughput and animal usage
Solution Approach 2:
Each animal becomes a universal testing platform capable of evaluating multiple biomaterials simultaneously through multi-capsule implantation. The barcode cell system provides a universal identification method that works across all materials tested in the same animal, enabling one animal to serve multiple testing functions
2Productivity
If the number of implantation sites per animal is increased, then more biomaterials can be screened per animal, but the complexity of tracking and identifying materials increases
Solution Approach 1:
The patent uses barcode cells as genetic copies of identification information embedded within each biomaterial capsule. Instead of complex external tracking systems, each capsule contains embedded genetic barcodes (SNP profiles) that serve as self-contained identification copies, simplifying the tracking of multiple materials across multiple implantation sites
Solution Approach 2:
Barcode cells serve as intermediary elements between the biomaterial and the identification system. These intermediate genetic markers facilitate straightforward tracking by providing a direct molecular link between the capsule contents and its identity, eliminating the need for complex mechanical or electronic tracking infrastructure
3Measurement precision
If barcode cells with SNP profiles are used to tag biomaterials, then identification accuracy is improved, but the complexity of the tagging system increases
Solution Approach 1:
The patent changes the identification parameter from external physical tags to intrinsic genetic parameters (SNP profiles). By utilizing natural genetic variations as barcodes, the system achieves high identification precision through biochemical parameter differences rather than complex physical tagging mechanisms, resolving the contradiction between accuracy and system complexity
Data Source
AI summary
Provided herein are high-throughput methods for genetic barcoding and analysis, e.g., for tagging each biomaterial capsule with a barcode cell. These barcode cells are derived from patient samples, and thus embody natural human genetic variation. Also provided are SNP panels that can be used as genetic barcodes to identify the identity of a cell.